SCHEMBL6250772

SCHEMBL6250772

O=CC1CC1c1ccc(O)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 4/20 0.47
ESR2 Q92731 9/20 0.38
ALDH5A1 P51649 1/20 0.38
ABAT P80404 1/20 0.38
DEGS1 O15121 1/20 0.37
KDM4E B2RXH2 3/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
ESR1 P03372 2/20 0.34
ALDH1A1 P00352 2/20 0.33
CYP3A4 P08684 2/20 0.33
MAPT P10636 2/20 0.33
NPC1 O15118 1/20 0.33
CA12 O43570 1/20 0.33
GMNN O75496 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
LMNA P02545 1/20 0.33
CA3 P07451 1/20 0.33
TYR P14679 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3901979 0.81 HTR2A (0.46) HSD17B10
SCHEMBL2360390 0.79 KDM1A (0.52) KDM1A
SCHEMBL2854689 0.79 KDM1A (0.52) KDM1AMEN1KMT2ANPC1CYP2C9
SCHEMBL7797793 0.79 DDB1 (0.37) KDM1AMEN1KMT2AALDH1A1MAPT
SCHEMBL11965121 0.79 HTR2A (0.44) ALDH1A1CYP3A4CYP2C9
SCHEMBL2324658 0.79 KDM1A (0.52) KDM1AMEN1KMT2ANPC1CYP2C9
SCHEMBL2359931 0.79 HTR2A (0.44) ALDH1A1CYP3A4CYP2C9
SCHEMBL2827719 0.79 KDM1A (0.52) KDM1AMEN1KMT2ANPC1CYP2C9
SCHEMBL26455980 0.79 TSHR (0.44) KDM1AKMT2AALDH1A1CA12CA1
SCHEMBL18567234 0.78 MAOB (0.48) KDM1AKDM4ECYP3A4MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7462713-B2 Tricyclic compounds protein kinase inhibitors for enhancing the efficacy of anti-neoplastic agents and radiation therapy AGOURON PHARMACEUTICALS, INC. (US) 2008-12-09 US disclosed
WO-2005051904-A2 NOVEL PROCESSES FOR THE SYNTHESIS OF CYCLOPROPYL COMPOUNDS PHARMACIA CORPORATION (US) 2005-06-09 WO disclosed